Small Molecules?
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT01727778
Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2012
Completion: Apr 30, 2014
Loading map...